The Committee for Medicinal Products for Human Use (CHMP) issued positive opinions for expanded use of Tresiba (insulin degludec) and Victoza (liraglutide) in type 2 diabetes. Once the European Commission approves the label expansion, physicians ... PharmaBiz, 3 weeks ago
Tresiba and Victoza Receive CHMP Decisions for Expanded Use - American Journal of Public Health, 4 weeks ago
Pending EC decision: Victoza, liraglutide, Opinion date: 20-Mar-2014 - European Medicines Agency, 4 weeks ago
Research and Markets (http://www.researchandmarkets.com/research/dxdmrx/victoza_obesity) has announced the addition of the "" report to their offering. After a more than decade-long dormancy, the obesity market is undergoing a revival with the ...Individual.com, 2 weeks ago Research and Markets: Victoza (Obesity) - Forecast and Market Analysis to 2022 TMC Net, 2 weeks ago RESEARCH AND MARKETS : Victoza (Obesity) - Forecast and Market Analysis to 2022 4 Traders, 2 weeks ago Global Obesity Therapeutics Market 2013-2019 - Safety Concerns Hinder Drug Performance Despite Large Market Opportunity Individual.com, 1 week ago
By (Reuters) - An experimental once-weekly medicine for type 2 diabetes developed by Eli Lilly and Co proved as effective in lowering blood sugar as Victoza from Danish drugmaker Novo Nordisk in an eagerly anticipated late stage study. The Lilly ...Business Insider, 1 month ago Lilly weekly diabetes drug as effective as market leader Victoza-study Reuters, 1 month ago UPDATE 1-Lilly weekly diabetes drug as effective as market leader Victoza-study Reuters UK, 1 month ago Lilly Diabetes Drug Could Breathe New Life into Pipeline Pharmaceutical Manufacturing Magazine, 1 month ago
Novo Nordisk's Victoza--FiercePharma file photo Eli Lilly is one step closer to launching its promising new diabetes drug dulaglutide--and one step closer to putting a crimp in Novo Nordisk's big-selling rival, Victoza . Lilly unveiled top-line ...FiercePharma, 1 month ago Lilly's diabetes drug matches Victoza Pharmafocus, 1 month ago Study: Eli Lilly's dulaglutide non-inferior to Novo Nordisk's Victoza FirstWord Pharma, 1 month ago Lilly Diabetes Drug Is as Good as Novo Market Leader Victoza Washington Post, 1 month ago
Physician Views: A Victoza competitor in waiting? Can Eli Lilly's dulaglutide make an impact in the GLP-1 agonist market?
Last week, Eli Lilly confirmed that in the head-to-head AWARD-6 study its experimental GLP-1 agonist dulaglutide demonstrated 'non-inferiority' to Novo Nordisk's market-leading Victoza brand . Dulaglutide is the first alternative drug in the ...FirstWord Pharma, 1 month ago Intranasal GLP-1 Promising in Pilot Study in Type 2 Diabetes Medscape, 2 weeks ago
Eli Lilly has been boosted by data from a head-to-head study which shows that its investigational GLP-1 glucagon-like peptide 1 receptor agonist dulaglutide is as effective as the market-leaderBig News Network, 1 month ago Lilly's diabetes drug dulaglutide matches Novo's Victoza Pharma Times, 1 month ago Is Eli Lilly's Bad News Priced In? Motley Fool, 1 month ago Eli Lilly's Dulaglutide: The Same, But Better Motley Fool, 1 month ago
Merck's ($MRK) Januvia, Novo Nordisk's ($NVO) Victoza and their brethren are in the clear. After a new round of safety reviews, U.S. and European regulators found little evidence that widely used diabetes drugs known as incretin mimetics cause ...FiercePharma, 1 month ago
thought Victoza would do ok until Bydureon came along as Victoza is a once-daily injection compared to Byetta which is injected twice-daily and was the only approved GLP-1 back when Victoza cameBig News Network, 1 month ago
Enrique Conterno, president of Lilly Diabetes Eli Lilly says its closely watched GLP-1 diabetes drug dulaglutide works as well as the market leading therapy Victoza, but isn't superior to the rival drug. That's going to be good enough for Lilly ...FierceBiotech, 1 month ago Lilly's GLP-1 contender takes a step forward Medical Marketing And Media, 1 month ago
The Firm is actively evaluating Byetta lawsuit claims on behalf of diabetics who allegedly developed pancreatitis, pancreatic cancer or thyroid cancer after taking the incretin mimetic. More than 30 federal cases have joined a federal diabetes drug ...PRWeb, 20 hours ago
on your WebpageAdd Widget >Get your members hooked!